FDA releases 14 drug rejection letters after 3-month pause
5 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.
Velocity
How fast coverage is spreading — measured hourly from article rate × source diversity. How this works →
The brief
"FDA releases 14 drug rejection letters after 3-month pause" is generating significant coverage in the Business category, with 5 articles from 5 distinct sources tracked by PULSE so far.
Outlets currently covering the story include Applied Clinical Trials Online, finance.biggo.com, BioSpace and Endpoints News. PULSE measures a story's velocity from how quickly new articles appear and how many independent newsrooms join the coverage.
This brief was generated by PULSE's extractive engine from coverage metadata only. The latest headlines from every source are listed below; the velocity chart shows how the story is developing in real time.
Generated by PULSE's extractive engine from coverage metadata only — no AI-written claims. Updated 1d ago.
Quick answers
Why is "FDA releases 14 drug rejection letters after 3-month pause" trending?
Because 5 independent news sources published 5 articles about it in a short window — a coverage burst PULSE classifies as a trend.
How does PULSE measure this trend?
PULSE scores velocity from the rate of new articles weighted by source diversity, snapshotted hourly. The full method is public on our methodology page.
Is this trend still active?
The status badge on this page updates hourly: rising, peaking, cooling, or archived once coverage stops for 48 hours.
Coverage (5)
- ACT Brief: FDA CRL Transparency Pause, Protocol-Centric Recruitment Model Shift, and Medical Affairs Integration in Development Applied Clinical Trials Online · 3d ago
- FDA's CRL Disclosure Freeze and DTC Ad Crackdown Likely Headed for Court, Sue Sutter and Derrick Gingery Warn finance.biggo.com · 3d ago
- FDA posts new rejection letters days after confirming pause BioSpace · 3d ago
- FDA returns to releasing pharma rejection letters with 14 new CRLs Endpoints News · 3d ago
- FDA releases 14 drug rejection letters after 3-month pause Fierce Biotech · 3d ago
Topics
Related trends
The F.D.A. Approves a New Pill to Slash Cholesterol Levels
The FDA has granted approval to Merck for a new, first-of-its-kind oral medication designed to reduce cholesterol levels.
Popular dog food recalled nationwide may contain sharp metal fragments, FDA says
FDA orders nationwide recall of a popular dog food after detecting possible sharp metal fragments
Sanofi snags FDA thumbs up for Sarclisa as 1st cancer drug delivered by on-body injector
8 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.
FDA recalls eye drops over possible 'foreign substance'
The FDA has issued a nationwide recall for 2.5 million bottles of prescription eye drops due to concerns regarding a foreign substance and sterility.
Millions of eye drops recalled nationwide due to potential foreign substance
The FDA has initiated a nationwide recall of 2.5 million bottles of prednisolone acetate eye drops citing the potential presence of a foreign substance.
Arsenic, lead and other metals in tampons aren’t harmful, FDA report concludes
5 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.